Thought Leaders

Contributed by:

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academic, industrial, patient, provider, and payer communities committed to personalized medicine from all parts of the healthcare world. For more information, visit personalizedmedicinecoalition.org. Jonathan Andrus. VP, Data and Study Operations, ­BioClinica, a global provider of ­clinical trial management ­services. Mr. Andrus is also chair of the DIA’s eClinical SIAC and on the board of directors with SCDM. For more information, visit ­bioclinica.com. Robin Arnold. VP, Product and Portfolio Strategy, IMS?Health, which plays a central role in advancing global ­healthcare, revealing the insights the market intelligence. For more information, visit imshealth.com. Scott Ballenger. Founder, Trial Acceleration ­Institute, which collaborates with the entire spectrum of clinical trial ­stakeholders to improve study cycle times. For more information, visit ­trialacceleration.com. Brett Barber. Director, Clinical Solutions, Kforce Clinical Research, is a provider of clinical trial resourcing solutions For more information, visit kforce.com/clinicalresearch. Gil Bashe. Executive VP, Makovsky + ­Company, an independent global public ­relations, investor relations and branding consultancy, focused in financial services, professional services, healthcare, technology, energy, and branding and ­interactive. For more information, visit makovsky.com. Helge BastiAn. VP, Research Biotech/Global ­Marketing, Business Development & Strategy, Sigma Life Science, a Sigma-Aldrich business that offers an array of biologically rich products and reagents that ­researchers use in scientific investigation. For more information, visit ­ sigmaaldrich.com/life-science.html. Jed Beitler. Chairman, CEO Worldwide, Sudler & Hennessey, a global healthcare marketing and communications ­organization with offices around the world. For more information, visit sudler.com. Jay Bigelow. President and CEO, MicroMass ­Communications, which offers ­capabilities in the application of ­behavioral science to marketing challenges. For more information, visit micromass.com. Wendy Blackburn. Executive VP, Intouch Solutions Inc., a digital marketing agency ­servicing the pharmaceutical industry. For more information, visit intouchsol.com. Chris Bogan. CEO, Best Practices, a research, ­consulting, and publishing firm that provides benchmarking ­focused on the pharmaceutical, biotech, ­medical device, and healthcare industries. For more information, best-in-class.com. Jay Bolling. President and CEO, Roska ­Healthcare Advertising, a ­full-service ad agency that integrates data and ­insight-driven marketing and ­advertising solutions. For more information, visit roskahealthcare.com. Jeff Burkel. Chief Operating Officer, ­MicroMass Communications, which offers ­capabilities in the application of behavioral science to marketing challenges. For more information, visit micromass.com. Sharon Callahan. CEO, LLNS, a healthcare advertising communications agency and part of the Diversified Agency Services (DAS) division of Omnicom. For more ­information, visit llns.com. David Chapman. Managing Partner, Ogilvy ­CommonHealth Worldwide, one ­of the largest healthcare ­communications networks. For more ­information, visit ogilvycommonhealth.com. Becky Chidester. President, Wunderman World Health, an interactive, digital healthcare agency. For more ­information, visit wunderman.com. John Cline. CEO, unithink, an electronic clinical research organization that helps clients make the most of the move from paper to digital. For more information, visit unithink.com. Kevin Coker. VP, US Oncology Research at US Oncology, a division of McKesson Corp., an integrated oncology company that unites one of the ­nation’s largest networks of community-based oncologists. For more information, visit ­usoncology.com and mckesson.com. Scott Cotherman. CEO, CAHG, an integrated ­marketing communications ­network model that is comprised of seven business units and provides brand stewardship throughout a brand’s ­lifecycle. For more information, visit cahg.com. Chris Cresswell. General Manager, Patient ­Innovations, DrFirst, which operates in the health IT (HIT) industry and is a provider of stand-alone electronic ­prescribing (e-prescribing) solutions. For more information, visit drfirst.com. David Cunningham. President and CEO, TrialCard, which offers solutions exclusively for the pharmaceutical industry to ­support direct-to-consumer and professional marketing, patient-assistance programs, and Phase IV clinical trials. For more information, visit trialcard.com. Michael Curry. Partner, The Curry Rockefeller Group, an independent, ­ full-service healthcare ­communications agency. For more ­information, visit curryrockefellergroup.com. Stephen Cutler, Ph.D. Senior VP and Chief Operating ­Officer, Kendle, a global clinical ­research organization providing the full range of early- to late-stage clinical ­development services for the world’s ­biopharmaceutical industry. For more ­information, visit kendle.com. Yvonne D’Amelio. Chief Financial Officer, Vox Medica, a community-driven marketing company specializing in ­healthcare. For more information, visit voxmedica.com. Bassil Dahiyat. CEO, Xencor Inc., which engineers biotherapeutics using a ­proprietary protein design ­automation technology platform. For more ­information, visit xencor.com. Jim Datin. Executive VP and Managing ­Director,Life Sciences Group, Safeguard ­Scientifics Inc., which provides growth capital for entrepreneurial and ­innovative life-sciences and technology ­companies. For more information, visit ­safeguard.com. Stephen DeCherney, M.D. Senior VP, Pharmaceutical and Life Sciences Operations, MedAssurant, a medical informatics solutions provider. For more information, visit medassurant.com. Jim DeSanti. CEO, PharmaVigilant, which offers solutions to address the ­complexities of global clinical ­research. For more information, visit ­pharmavigilant.com. Phil Deschamps. President and CEO, GSW Worldwide, an inVentiv Health company, a healthcare advertising agency. For more information, visit gsw-w.com. Patrick Durbin. President, BioPharma Services, Thermo Fisher Scientific, a provider of scientific services. For more ­information, visit thermoscientific.com. Brian G.M. Durie, M.D. Chairman of the International Myeloma Foundation and Medical Director, Aptium Oncology Myeloma Consortium (AMyC) ­Aptium Oncology, which works with hospitals and physicians to develop ­centers designed to accommodate the future of cancer care. For more information, visit ­aptiumoncology.com. David Fishman. President, Snowfish, which provides insights to healthcare, ­ life-sciences, and biotechnology companies. For more information, visit ­snowfish.net. Patrick Flochel. Life Sciences Leader for EMEIA, Ernst & Young, a global provider of ­assurance, tax, transaction, and advisory services. For more information, visit ey.com. Chris Garabedian. President and CEO, AVI BioPharma, which is focused on the discovery and development of novel ­ RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets. For more information, visit avibio.com. Joseph Gattuso. Executive VP, Chief Strategic Officer, Ogilvy CommonHealth Worldwide, one of the largest healthcare ­communications networks. For more ­information, visit ogilvycommonhealth.com. Matt Giegerich. Chairman and CEO, Ogilvy ­CommonHealth Worldwide, one of the largest healthcare ­communications networks. For more ­information, visit ogilvycommonhealth.com. Rich Gliklich, M.D. President and CEO, Outcome, a provider of patient registries, ­studies, and technologies for ­evaluating real-world outcomes. For more ­information, visit outcome.com. Mark A. Goldberg, M.D. Chief Operating Officer, Parexel ­International, a global biopharmaceutical services ­organization that provides the right level of guidance to bring safe and ­effective treatments to patients sooner. For more information, visit parexel.com. Gene Guselli. Co-Founder, President, and CEO, ­InfoMedics Inc., a provider of ­patient feedback solutions for pharmaceutical companies. For more ­information, visit infomedics.com. Luis Gutierrez. Senior VP, Pharmaceutical and ­­­ Life-Sciences Operations, MedAssurant, a medical ­informatics solutions provider. For more ­information, visit medassurant.com. Michael Harte. Founder and President, The Harte Group, a functional services ­management organization (FSMO), which leverages the expertise, flexibility, and experience of functional service providers to deliver trial execution solutions. For more ­information, visit hartegroup.com. Ron Helm. CEO, Pacific Biomarkers Inc. (PBI), a biomarker laboratory services provider in the drug development industry supporting preclinical and Phase I-IV studies. For more information, visit pacbio.com. John Hudak. Founder and President, Criterium, a global, full-service, and ­ technology-driven contract research organization that offers a mix of high-quality, innovative clinical research solutions for the biopharmaceutical, pharmaceutical, medical device, and CRO industries. For more ­information, visit criteriuminc.com. Kim Huggins. Owner and President, K HR Solutions LLC, a human resources consulting firm that helps transform ­individuals and corporate groups into effective leaders and results-oriented teams. For more information, visit khrsolutions.com. Max Jackson. CEO, EMEA/Asia Pacific, Sudler & ­Hennessey, a global healthcare -marketing and communications ­organization with offices around the world. For more information, visit sudler.com. Joe Jimenez. CEO, Novartis, a global healthcare company whose diverse portfolio spans innovative pharmaceuticals, generics, vaccines and diagnostics, and ­consumer health products. For more ­information, visit novartis.com. Stephen Jones, M.D. Medical Director and Co-Chair of the Breast Cancer Committee, US ­Oncology Research at US Oncology, a division of McKesson Corp., an integrated oncology company that unites one of the nation’s largest networks of community-based oncologists. For more ­information, visit usoncology.com or mckesson.com. Dan Junius. President and CEO, ImmunoGen Inc., a developer of targeted anticancer ­therapeutics. For more ­information, visit immunogen.com. Marcia Kean. CEO, Feinstein Kean Healthcare, a full-service communications and business consulting firm ­specializing in the healthcare industry. For more information, visit fkhealth.com. Rick Keefer. President and CEO, Publicis ­Touchpoint Solutions Inc., which provides a comprehensive and ­integrated array of multichannel outsourced message solutions to the life-sciences industry. For more information, visit ­publicistouchpointsolutions.com. Michael Kleinrock. Director, Thought Leadership, IMS Health, which plays a central role in advancing global healthcare, ­revealing the insights market intelligence. For more information, visit imshealth.com. Jim Knipper. Founder and CEO, J. Knipper and Company Inc., a provider of ­healthcare marketing solutions in direct marketing, sampling, compliance, ­information technology, and sales force ­productivity. For more information, visit ­knipper.com. Dave Lacey. Senior VP, Discovery Research, Amgen, a human therapeutics company in the biotechnology ­industry. For more information, visit amgen.com. Nicholas Landekic. President, CEO, and Director, ­PolyMedix, which is developing novel, first-in-class therapies for serious, life-threatening, acute disorders. For more information, visit ipolymedix.com. Rich Levy. Executive VP, Client Solutions, ­inVentiv Health, which provides customized solutions for every type of healthcare brand, at every stage. For more information, visit inventivhealth.com. Rob Likoff. Co-CEO, Group DCA, a PDI ­company, offers brand-building digital outreach as part of a ­multichannel solution. For more­ ­information, visit groupdca.com. Nancy Lurker. CEO, PDI Inc., a provider of ­integrated multichannel ­promotion outsource services to both ­established and emerging U.S.-based ­biopharmaceutical companies. For more ­information, visit pdi-inc.com. James Macdonell. VP, Patni Americas, a global IT ­services company that delivers ­solutions to pharmaceutical, biotechnology, and medical-device clients. For more information, visit patni.com/life-sciences/overview.aspx. Jeanne Male. President and CEO, Emp-Higher ­Performance, a consultancy that helps build higher employee ­performance. For more information, visit ­emphigher.com. JeanMarie Markham. CEO, Clinlogix, a next-generation clinical research organization that supports the clinical development of drugs, biologics, devices, and diagnostics in discovery and Phase I through Phase IV ­clinical trials. For more information, visit ­clinlogix.com. Neil Matheson. CEO, Huntsworth Health, a global family of agencies that provides a full continuum of consulting and communications services to the healthcare and well-being industry. For more information, visit huntsworthhealth.com. Lynn Meyer. Managing Partner, IntegReview ­Ethical Review Board, which is ­committed to protecting the rights and welfare of human subjects participating in research. For more information, visit ­integreview.com. Colin Miller, Ph.D. Senior VP, Medical Affairs, BioClinica, a global provider of clinical trial management services. For more information, visit bioclinica.com. Richard Minoff. Managing Partner, 1 Global ­Partners LLC, a consultancy focused on strategic planning and ­commercialization, marketing and life-cycle management, and building high-performance organizations. For more information, e-mail Mr. Minoff at ­rminoff@1gblp.com. Ed Mitzen. Partner, FingerPaint Marketing, a full-service advertising agency. For more information, visit ­fingerpaintmarketing.com. Simon E. Moroney, Ph.D. CEO, MorphoSys AG, which is ­building a strong therapeutic ­antibody pipeline with more than 60 projects in development. For more ­information, visit morphosys.com. Michael Naimoli. Worldwide Managing Director, ­Microsoft Life Sciences, which is committed to improving health around the world through software innovation. For more information, visit microsoft.com. Bill Newell. CEO, Sutro Biopharma, a ­biopharmaceutical company ­developing novel and biosuperior protein therapeutics with improved ­pharmaceutical properties. For more ­information, visit sutrobio.com. Bob Norris. President and CEO, Complete Healthcare Communications, a strategic medical communications agency that specializes in publication ­planning. For more information, visit chcinc.com. John Nosta. Chief Creative Officer, Ogilvy ­CommonHealth Medical Education, one of the largest healthcare communications networks. For more information, visit ­ogilvycommonhealth.com. Terry Nugent. VP, Marketing, Medical Marketing Service Inc., which provides lists that maximize results and ­minimize costs in the dynamic medical ­marketing industry. For more information, visit mmslists.com. Cathy Pagano. President, The Institute for ­Continuing Healthcare Education, a provider of ­ evidence-based, clinically relevant certified continuing education to physicians, nursing professionals, pharmacists, and other allied healthcare professionals. For more ­information, visit iche.edu. Michael Parisi. Managing Partner, Ogilvy CommonHealth Worldwide, one of the largest healthcare ­communications networks. For more ­information, visit ogilvycommonhealth.com. Michael Parks. Executive VP, Public Relations and Marketing Communications, Vox Medica, a ­community-driven marketing company ­specializing in healthcare. For more ­information, visit voxmedica.com. Julian M. Parreño. Senior Account Director, Datacore Marketing, a KBM Group ­Company, part of the Wunderman Network, which combines data-driven ­intelligence with one-to-one ­marketing ­innovation. For more information, visit ­datacoremarketing.com. Vince Parry. Chief Branding Officer, Y Brand, a ­division of Ignite Health, which works exclusively in the healthcare and wellness field on creating impactful brand identities. For more information, visit ybrand.com. Donald Phillips, Pharm.D. CEO, Vox Medica, a ­ community-driven marketing company specializing in ­healthcare. For more information, visit voxmedica.com. Frank X. Powers. President, Dudnyk, an ­independently owned, full-service branding, medical marketing, and ­advertising agency. For more information, visit dudnyk.com. Jennifer Price. Senior Director, Clinical Solutions, BioClinica, a global provider of ­clinical trial management services. For more information, visit bioclinica.com. Charlene Prounis. Managing Partner, Flashpoint ­Medica, a full-service professional healthcare advertising agency within the worldwide Omnicom Diversified Agency Services network. For more ­information, visit flashpointmedica.com. John Racik. President and CEO, Stonefly ­Communications Group, an ­inVentiv Health ­company, and a patient-focused, insight-driven health, and ­ well-being advertising agency. For more information, visit stoneflycommunications.com. Julia Ralston, R.Ph. President and CEO, MedErgy ­HealthGroup, a provider of ­evidence-based communication solutions through the synergistic blend of our strategic, scientific, and creative skills. For more information, visit medergygroup.com. Will Reese. Chief Innovation Officer, Cadient Group, an ­interactive marketing company offering full marketing agency services emphasizing digital solutions that targets all businesses and industries. For more information, visit cadient.com. Ken Ribotsky. President and CEO, The Core Nation, a family of healthcare marketing and medical communications companies (Core-Create, Brandkarma, and Alpha & Omega) that offers strategic, ­branding, and creative consulting services. For more information, visit thecorenation.com. Doug Ringler. CEO, Tolerx, a biopharmaceutical company developing novel ­therapies to treat autoimmune ­diseases and cancer by normalizing the ­immune response. For more information, visit tolerx.com. Charles Rockefeller. Partner, The Curry Rockefeller Group, an independent, full-service healthcare communications agency. For more information, visit ­curryrockefellergroup.com. John Ross. Chief Operating Officer, SDI, a healthcare analytics organization. For more information, visit ­sdihealth.com. Keith Ruark. VP, Avos Consulting, a part of INC Research, which helps customers address current and future ­economic concerns and successfully ­compete in the increasingly challenging global environment. For more information, visit ­incresearch.com/avosconsulting.aspx. Peter Sandford. Executive VP, NXLevel Solutions, a developer of technology-delivered learning applications and PharmaCertify, e-learning training for the life sciences. For more ­information, visit nxlevelsolutions.com. Deborah Schnell. President, Sales and Strategic ­Planning, Healthy Advice Networks, a provider of trusted, relevant, and easy-to-understand health information to ­consumers and healthcare professionals when and where they need it. For more information, visit healthyadvicenetworks.com. Tim Shannon. Venture Partner, Canaan Partners, a global venture capital firm that ­invests in people who turn ­visionary ideas into valuable and significant technology and healthcare companies. For more information, visit canaan.com. Alison Shurell. VP, Life Sciences Product Marketing, IntraLinks, a global provider of ­software-as-a-service solutions for securely managing content and exchanging critical business information. For more ­information, visit intralinks.com. Paul Simms. Chairman, eyeforpharma, which provides forums, industry insights, and intelligence. For more ­information, visit ­eyeforpharma.com. David Smoller. President, Research Biotech, Sigma Life ­Science, a Sigma-Aldrich ­business that offers an array of ­biologically rich products and reagents that researchers use in scientific investigation. For more information, visit sigmaaldrich.com/life-science.html. Mike Soenen. President and CEO, ClearTrial, a provider of clinical trial operations software to make the planning, forecasting, and tracking of ­clinical project and financial performance more efficient. For more information, visit cleartrial.com. Nagaraja Srivatsan. Senior VP and Head of Life Science, North America, Cognizant, a global services partner for the ­life-sciences industry. For more information, visit cognizant.com. Bill Taaffe. President, Corporate Development, Icon, a global provider of outsourced development services that specializes in the planning, management, execution and analysis of Phase IIb – IV clinical trials to the pharmaceutical, biotechnology, and medical-device industries. For more information, visit iconplc.com. Brad Thompson. CEO, Oncolytics Biotech Inc., a biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. For more information, visit oncolyticsbiotech.com. Al Topin. President, Topin & Associates, an ­independent, full-service, medical marketing communications ­company. For more information, visit topin.com. Terrence Tormey. CEO and President, Prevention ­Pharmaceuticals Inc., which actively pursues compelling nutraceutical product opportunities. For more information, visit preventionpharmaceuticals.com. Tim Tyson. CEO, Aptuit, a provider of drug ­development solutions to ­pharmaceutical and biotechnology innovators worldwide. For more ­information, visit aptuit.com. John M. Vann. Executive VP, Global Corporate ­Development, Chiltern, a ­ full-­service, global contract ­research organization with experience in the ­management of Phase I-IV clinical trials across a broad range of therapeutic areas and contract staffing solutions. For more ­information, visit chiltern.com. Josef Von Rickenbach. Chairman and CEO, Parexel ­International, a global ­biopharmaceutical services ­organization that provides the right level of guidance to bring safe and ­effective treatments to patients sooner. For more information, visit parexel.com. Matt Wallach. Chief Strategy Officer, Veeva ­Systems, a provider of SaaS-based CRM solutions for the global ­ life-sciences industry. For more information, visit veevasystems.com. Marc Weiner. Managing Partner, Ogilvy ­CommonHealth Worldwide, one of the largest healthcare ­communications networks. For more ­information, visit ogilvycommonhealth.com. Stephen Wray. President and CEO, Cadient Group, an interactive marketing company offering full marketing agency services emphasizing digital solutions that ­target all businesses and industries. For more information, visit cadient.com. Kristie Zinselmeier. Director of Marketing, BioPharma Solutions, Baxter, a business unit of Baxter that partners with ­pharmaceutical companies to support their commercialization objectives by providing ­scientific expertise, sterile manufacturing ­solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face. For more information, visit ­baxterbiopharmasolutions.com. Jeff Zucker. Senior Director and Global Head, Patient Recruitment, Kendle, a global clinical research organization providing the full range of ­ early- to late-stage clinical development services for the world’s biopharmaceutical industry. For more information, visit kendle.com.

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK